Related Experiment Videos
Cyclic nucleotide metabolism and vasodilation in canine mesenteric artery
The American Journal of Physiology
|February 1, 1977
Summary
Cyclic adenosine monophosphate (cAMP) and its metabolites, not cAMP itself, cause vasodilation in canine mesenteric arteries. Dibutyryl cAMP (DBcAMP) also induced vasodilation, but with a delayed onset compared to cAMP.
Area of Science:
- Pharmacology
- Physiology
- Biochemistry
Background:
- Cyclic adenosine monophosphate (cAMP) plays a crucial role in cellular signaling.
- Understanding the metabolism and vasodilator effects of cAMP and its analogs is important for cardiovascular research.
Purpose of the Study:
- To investigate the uptake and metabolism of radioisotopically labeled cAMP and dibutyryl cAMP (DBcAMP) in canine mesenteric arteries.
- To correlate the vasodilator properties of cAMP and DBcAMP with their metabolic fate.
Main Methods:
- In vitro incubation of canine mesenteric arteries with radiolabeled cAMP and DBcAMP.
- Measurement of intracellular tissue uptake using radioisotope counting.
- Separation and identification of labeled metabolites via thin-layer chromatography.
- Assessment of vasodilation in vivo.
Main Results:
- Extracellularly, cAMP was metabolized to adenosine monophosphate (AMP), adenosine, and inorganic phosphate (Pi).
- Intracellularly, DBcAMP was metabolized to monobutyryl cAMP (MBcAMP).
- Both cAMP and DBcAMP induced vasodilation; DBcAMP produced a greater effect but with a slower onset (12 min) compared to cAMP (90 s).
Conclusions:
- The vasodilator effects of cAMP and DBcAMP are linked to their metabolic pathways.
- Extracellular metabolism of cAMP produces metabolites responsible for vasodilation.
- DBcAMP's delayed but potent vasodilation suggests a different metabolic or signaling mechanism compared to cAMP.